Best and Brightest Forum on Medical Innovation: Washington, DC
Best & Brightest Forum on Medical Innovation: Washington, DC
June 12, 2009
On June 12, 2009, the Council for American Medical Innovation and the Aspen Institute co-hosted the third “Best & Brightest Forum on Medical Innovation” in Washington, D.C.
Over 135 policy experts, innovation stakeholders and members of the media attended to hear the discussion examining the political landscape, the case for new policy, and the economics of medical innovation.
Council President Dick Gephardt opens the Best & Brightest Forum on Medical Innovation in Washington, D.C.Former House Majority Leader and Council President Dick Gephardt opened the forum by unveiling the Council’s new policy platform, and introducing Senator Arlen Specter (D-PA). Senator Specter provided the keynote address and took questions from the audience.
Two panel discussions followed, featuring:
- Paul Begala, CNN political contributor, and research professor at Georgetown University’s Public Policy Institute (Panel 1 Moderator)
- Rita Colwell, Ph.D., former director of the National Science Foundation; Senior Advisor, Canon US Life Sciences, Inc.; and, Distinguished University Professor at the University of Maryland at College Park and Johns Hopkins University Bloomberg School of Public Health
- Dick Gephardt, Former House Majority Leader and President of the Council for American Medical Innovation
- Brett P. Giroir, M.D., Vice Chancellor of Research, The Texas A&M University System
- Alicia Löffler, Ph.D., Director and Clinical Professor of Biotechnology, Kellogg School of Management, Northwestern University
- Michelle McMurry, M.D., Ph.D., Director, Health, Biomedical Science and Society Initiative, The Aspen Institute (Panel 2 Moderator)
- Billy Tauzin, President and CEO, Pharmaceutical Research and Manufacturers of America (PhRMA)
- Mary Woolley, President, Research!America
Senator Arlen Specter takes questions from the audience at the Best & Brightest Forum on Medical Innovation. The first panel focused on the challenges facing the United States in maintaining its global leadership position in medical innovation, and how an innovation agenda fits into the current health reform debate. The second panel centered on the economic value of medical innovation and addressed policies that would facilitate future innovations in America.
The Aspen Institute’s Michelle McMurry closed the forum by encouraging attendees to contact the Council with continuing ideas for ensuring a strong innovation agenda in the U.S.
Watch the event video: